297 related articles for article (PubMed ID: 23431285)
1. Molecular Implications of the PPARs in the Diabetic Eye.
Ciudin A; Hernández C; Simó R
PPAR Res; 2013; 2013():686525. PubMed ID: 23431285
[TBL] [Abstract][Full Text] [Related]
2. PPARα Agonist Oral Therapy in Diabetic Retinopathy.
Tomita Y; Lee D; Tsubota K; Kurihara T
Biomedicines; 2020 Oct; 8(10):. PubMed ID: 33086679
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the vitreous fluid analysis in the translational research of diabetic retinopathy.
Simó-Servat O; Hernández C; Simó R
Mediators Inflamm; 2012; 2012():872978. PubMed ID: 23028204
[TBL] [Abstract][Full Text] [Related]
4. Peroxisome Proliferated Activated Receptors (PPARs): Opportunities and Challenges for Ocular Therapy.
Khatol P; Saraf S; Jain A
Crit Rev Ther Drug Carrier Syst; 2018; 35(1):65-97. PubMed ID: 29611471
[TBL] [Abstract][Full Text] [Related]
5. Intravitreal Anti-Vascular Endothelial Growth Factor Agents for the Treatment of Diabetic Retinopathy: A Review of the Literature.
Chatziralli I; Loewenstein A
Pharmaceutics; 2021 Jul; 13(8):. PubMed ID: 34452097
[No Abstract] [Full Text] [Related]
6. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.
Wong TY; Sabanayagam C
Ophthalmologica; 2020; 243(1):9-20. PubMed ID: 31408872
[TBL] [Abstract][Full Text] [Related]
7. Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications.
Simó R; Hernández C;
Br J Ophthalmol; 2012 Oct; 96(10):1285-90. PubMed ID: 22887976
[TBL] [Abstract][Full Text] [Related]
8. Prevention and treatment of diabetic retinopathy: evidence from large, randomized trials. The emerging role of fenofibrate.
Simó R; Hernández C
Rev Recent Clin Trials; 2012 Feb; 7(1):71-80. PubMed ID: 21864248
[TBL] [Abstract][Full Text] [Related]
9. Current trends in the pharmacotherapy of diabetic retinopathy.
Kumar B; Gupta SK; Saxena R; Srivastava S
J Postgrad Med; 2012; 58(2):132-9. PubMed ID: 22718058
[TBL] [Abstract][Full Text] [Related]
10. Nutrition for diabetic retinopathy: plummeting the inevitable threat of diabetic vision loss.
Sharma Y; Saxena S; Mishra A; Saxena A; Natu SM
Eur J Nutr; 2017 Sep; 56(6):2013-2027. PubMed ID: 28258307
[TBL] [Abstract][Full Text] [Related]
11. Diabetic retinopathy: new therapeutic perspectives based on pathogenic mechanisms.
Hernández C; Simó-Servat A; Bogdanov P; Simó R
J Endocrinol Invest; 2017 Sep; 40(9):925-935. PubMed ID: 28357783
[TBL] [Abstract][Full Text] [Related]
12. Association of Peroxisome Proliferator-Activated Receptors (PPARs) with Diabetic Retinopathy in Human and Animal Models: Analysis of the Literature and Genome Browsers.
Tajnšek Š; Petrovič D; Globočnik Petrovič M; Kunej T
PPAR Res; 2020; 2020():1783564. PubMed ID: 32190036
[TBL] [Abstract][Full Text] [Related]
13. Managing diabetic macular edema: The leading cause of diabetes blindness.
Romero-Aroca P
World J Diabetes; 2011 Jun; 2(6):98-104. PubMed ID: 21860693
[TBL] [Abstract][Full Text] [Related]
14. Novel approaches for treating diabetic retinopathy based on recent pathogenic evidence.
Simó R; Hernández C
Prog Retin Eye Res; 2015 Sep; 48():160-80. PubMed ID: 25936649
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of PPARα agonists on diabetic retinopathy in type 1 diabetes models.
Chen Y; Hu Y; Lin M; Jenkins AJ; Keech AC; Mott R; Lyons TJ; Ma JX
Diabetes; 2013 Jan; 62(1):261-72. PubMed ID: 23043158
[TBL] [Abstract][Full Text] [Related]
16. Spermine oxidase: A promising therapeutic target for neurodegeneration in diabetic retinopathy.
Narayanan SP; Shosha E; D Palani C
Pharmacol Res; 2019 Sep; 147():104299. PubMed ID: 31207342
[TBL] [Abstract][Full Text] [Related]
17. Glucocorticoids: structure, signaling and molecular mechanisms in the treatment of diabetic retinopathy and diabetic macular edema.
Zhang X; Wang N; Schachat AP; Bao S; Gillies MC
Curr Mol Med; 2014 Mar; 14(3):376-84. PubMed ID: 24467200
[TBL] [Abstract][Full Text] [Related]
18. Pan-retinal photocoagulation and other forms of laser treatment and drug therapies for non-proliferative diabetic retinopathy: systematic review and economic evaluation.
Royle P; Mistry H; Auguste P; Shyangdan D; Freeman K; Lois N; Waugh N
Health Technol Assess; 2015 Jul; 19(51):v-xxviii, 1-247. PubMed ID: 26173799
[TBL] [Abstract][Full Text] [Related]
19. [Diabetic retinopathy].
Barth T; Helbig H
Klin Monbl Augenheilkd; 2021 Oct; 238(10):1143-1159. PubMed ID: 34380155
[TBL] [Abstract][Full Text] [Related]
20. Treatment of diabetic retinopathy: Recent advances and unresolved challenges.
Stewart MW
World J Diabetes; 2016 Aug; 7(16):333-41. PubMed ID: 27625747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
